Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson’s Disease Motor Subtypes: A More Accurate Judgment

Background. The relationship between the levodopa challenge test (LDCT) and postoperative subthalamic nucleus-deep brain stimulation (STN-DBS) benefits is controversial in patients with Parkinson’s disease (PD). We aim to evaluate the value of total levodopa response (TLR) and symptom levodopa respo...

Full description

Saved in:
Bibliographic Details
Main Authors: Zijian Zheng, Zixiao Yin, Bohan Zhang, Houyou Fan, Dan Liu, Yuancheng Zhou, Jian Duan, Dongwei Zhou, Xi Wu, Guohui Lu
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2021/4762027
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524883526254592
author Zijian Zheng
Zixiao Yin
Bohan Zhang
Houyou Fan
Dan Liu
Yuancheng Zhou
Jian Duan
Dongwei Zhou
Xi Wu
Guohui Lu
author_facet Zijian Zheng
Zixiao Yin
Bohan Zhang
Houyou Fan
Dan Liu
Yuancheng Zhou
Jian Duan
Dongwei Zhou
Xi Wu
Guohui Lu
author_sort Zijian Zheng
collection DOAJ
description Background. The relationship between the levodopa challenge test (LDCT) and postoperative subthalamic nucleus-deep brain stimulation (STN-DBS) benefits is controversial in patients with Parkinson’s disease (PD). We aim to evaluate the value of total levodopa response (TLR) and symptom levodopa response (SLR) in predicting postoperative improvement in different PD motor subtypes. Methods. Studies were split into a training set (147 patients) and a validation set (304 patients). We retrospectively collected data from 147 patients who received the Unified Parkinson’s Disease Rating Scale- (UPDRS-) III and the Parkinson’s Disease Questionnaire- (PDQ-) 39 evaluation. Patients were classified into tremor-dominant (TD), akinetic-rigid-dominant (AR), and mixed (MX) groups. Clinically important difference (CID) was employed to dichotomize DBS effects. For patients in each subtype group from the training set, we used the correlation and receiver operator characteristic (ROC) curve analyses to explore the strength of their relations. Areas under the curve (AUCs) were calculated and compared through the DeLong test. Results developed from the training set were applied into the validation set to predict postoperative improvement in different PD motor subtypes. Results. In the validation cohort, TLR significantly correlated with postoperative motor (p<0.001) and quality of life (QOL) (p<0.001) improvement in the MX group. The AUC between TLR and UPDRS-III (TU) is 0.800. The AUC between TLR and PDQ-39 (TP) is 0.770. An associated criterion in both TU and TP is around 50%. In the AR group, strong correlation was only found in SLR and PDQ-39 (SP) (p<0.001). And the AUC of SP is significantly larger than that in TLR and PDQ-39 (TP) (p=0.034). An associated criterion in SP is around 37%. No significant correlation was found in the TD group. Conclusions. We provide a more accurate judgment for LDCT. TLR strongly correlated with postoperative UPDRS-III and PDQ-39 improvement in MX patients. A TLR>50% may indicate a higher possibility of clinically meaningful benefits from STN-DBS comparing to medication only. SLR can well predict QOL improvement in AR patients. Similarly, a SLR>37% may indicate a higher possibility of clinically significant benefits from STN-DBS. LDCT provides limited information for TD patients.
format Article
id doaj-art-a63dca269f464df4a42a74cda71de2d7
institution Kabale University
issn 2090-5904
1687-5443
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Neural Plasticity
spelling doaj-art-a63dca269f464df4a42a74cda71de2d72025-02-03T05:47:08ZengWileyNeural Plasticity2090-59041687-54432021-01-01202110.1155/2021/47620274762027Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson’s Disease Motor Subtypes: A More Accurate JudgmentZijian Zheng0Zixiao Yin1Bohan Zhang2Houyou Fan3Dan Liu4Yuancheng Zhou5Jian Duan6Dongwei Zhou7Xi Wu8Guohui Lu9Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Neurosurgery, Changhai Hospital of the Second Military Medical University of Chinese PLA, Shanghai, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaBackground. The relationship between the levodopa challenge test (LDCT) and postoperative subthalamic nucleus-deep brain stimulation (STN-DBS) benefits is controversial in patients with Parkinson’s disease (PD). We aim to evaluate the value of total levodopa response (TLR) and symptom levodopa response (SLR) in predicting postoperative improvement in different PD motor subtypes. Methods. Studies were split into a training set (147 patients) and a validation set (304 patients). We retrospectively collected data from 147 patients who received the Unified Parkinson’s Disease Rating Scale- (UPDRS-) III and the Parkinson’s Disease Questionnaire- (PDQ-) 39 evaluation. Patients were classified into tremor-dominant (TD), akinetic-rigid-dominant (AR), and mixed (MX) groups. Clinically important difference (CID) was employed to dichotomize DBS effects. For patients in each subtype group from the training set, we used the correlation and receiver operator characteristic (ROC) curve analyses to explore the strength of their relations. Areas under the curve (AUCs) were calculated and compared through the DeLong test. Results developed from the training set were applied into the validation set to predict postoperative improvement in different PD motor subtypes. Results. In the validation cohort, TLR significantly correlated with postoperative motor (p<0.001) and quality of life (QOL) (p<0.001) improvement in the MX group. The AUC between TLR and UPDRS-III (TU) is 0.800. The AUC between TLR and PDQ-39 (TP) is 0.770. An associated criterion in both TU and TP is around 50%. In the AR group, strong correlation was only found in SLR and PDQ-39 (SP) (p<0.001). And the AUC of SP is significantly larger than that in TLR and PDQ-39 (TP) (p=0.034). An associated criterion in SP is around 37%. No significant correlation was found in the TD group. Conclusions. We provide a more accurate judgment for LDCT. TLR strongly correlated with postoperative UPDRS-III and PDQ-39 improvement in MX patients. A TLR>50% may indicate a higher possibility of clinically meaningful benefits from STN-DBS comparing to medication only. SLR can well predict QOL improvement in AR patients. Similarly, a SLR>37% may indicate a higher possibility of clinically significant benefits from STN-DBS. LDCT provides limited information for TD patients.http://dx.doi.org/10.1155/2021/4762027
spellingShingle Zijian Zheng
Zixiao Yin
Bohan Zhang
Houyou Fan
Dan Liu
Yuancheng Zhou
Jian Duan
Dongwei Zhou
Xi Wu
Guohui Lu
Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson’s Disease Motor Subtypes: A More Accurate Judgment
Neural Plasticity
title Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson’s Disease Motor Subtypes: A More Accurate Judgment
title_full Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson’s Disease Motor Subtypes: A More Accurate Judgment
title_fullStr Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson’s Disease Motor Subtypes: A More Accurate Judgment
title_full_unstemmed Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson’s Disease Motor Subtypes: A More Accurate Judgment
title_short Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson’s Disease Motor Subtypes: A More Accurate Judgment
title_sort levodopa challenge test predicts stn dbs outcomes in various parkinson s disease motor subtypes a more accurate judgment
url http://dx.doi.org/10.1155/2021/4762027
work_keys_str_mv AT zijianzheng levodopachallengetestpredictsstndbsoutcomesinvariousparkinsonsdiseasemotorsubtypesamoreaccuratejudgment
AT zixiaoyin levodopachallengetestpredictsstndbsoutcomesinvariousparkinsonsdiseasemotorsubtypesamoreaccuratejudgment
AT bohanzhang levodopachallengetestpredictsstndbsoutcomesinvariousparkinsonsdiseasemotorsubtypesamoreaccuratejudgment
AT houyoufan levodopachallengetestpredictsstndbsoutcomesinvariousparkinsonsdiseasemotorsubtypesamoreaccuratejudgment
AT danliu levodopachallengetestpredictsstndbsoutcomesinvariousparkinsonsdiseasemotorsubtypesamoreaccuratejudgment
AT yuanchengzhou levodopachallengetestpredictsstndbsoutcomesinvariousparkinsonsdiseasemotorsubtypesamoreaccuratejudgment
AT jianduan levodopachallengetestpredictsstndbsoutcomesinvariousparkinsonsdiseasemotorsubtypesamoreaccuratejudgment
AT dongweizhou levodopachallengetestpredictsstndbsoutcomesinvariousparkinsonsdiseasemotorsubtypesamoreaccuratejudgment
AT xiwu levodopachallengetestpredictsstndbsoutcomesinvariousparkinsonsdiseasemotorsubtypesamoreaccuratejudgment
AT guohuilu levodopachallengetestpredictsstndbsoutcomesinvariousparkinsonsdiseasemotorsubtypesamoreaccuratejudgment